Terms: = Lung cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
28 results:
1. Elk1 enhances inflammatory cell infiltration and exacerbates acute lung injury/acute respiratory distress syndrome by suppressing fcgr2b transcription.
Wei S; Ling D; Zhong J; Chang R; Ling X; Chen Z; Duan R
Mol Med; 2024 Apr; 30(1):53. PubMed ID: 38649840
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (cd32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract] [Full Text] [Related]
3. High levels of PD-L1 on platelets of NSCLC patients contributes to the pharmacological activity of Atezolizumab.
Colarusso C; Falanga A; Terlizzi M; De Rosa I; Somma P; Sommella EM; Caponigro V; Panico L; Salviati E; Campiglia P; Salatiello G; Tramontano T; Maiolino P; Pinto A; Sorrentino R
Biomed Pharmacother; 2023 Dec; 168():115709. PubMed ID: 37857253
[TBL] [Abstract] [Full Text] [Related]
4. Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.
Rojo-Tolosa S; Sánchez-Martínez JA; Pineda-Lancheros LE; Gálvez-Navas JM; González-Gutiérrez MV; Jiménez-Gálvez G; Pérez-Ramírez C; Morales-García C; Jiménez-Morales A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108192
[TBL] [Abstract] [Full Text] [Related]
5. Short-term association of PM 2.5 /PM 10 on lung cancer mortality in Wuhai city, China (2015-2019): a time series analysis.
Liu Y; Liu C; Song Y; Zhao J; Gao Y; Zhao L; Cao N; Xu D; Li H; Li H
Eur J Cancer Prev; 2022 Nov; 31(6):530-539. PubMed ID: 35671253
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.
Liu Q; Huang Q; Yu Z; Wu H
Clin Respir J; 2022 Mar; 16(3):216-225. PubMed ID: 35081265
[TBL] [Abstract] [Full Text] [Related]
7. Application of artificial intelligence in the diagnosis of multiple primary lung cancer.
Li X; Hu B; Li H; You B
Thorac Cancer; 2019 Nov; 10(11):2168-2174. PubMed ID: 31529684
[TBL] [Abstract] [Full Text] [Related]
8. In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by cd32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Caratelli S; Arriga R; Sconocchia T; Ottaviani A; Lanzilli G; Pastore D; Cenciarelli C; Venditti A; Del Principe MI; Lauro D; Landoni E; Du H; Savoldo B; Ferrone S; Dotti G; Sconocchia G
Int J Cancer; 2020 Jan; 146(1):236-247. PubMed ID: 31479522
[TBL] [Abstract] [Full Text] [Related]
9. The
Maloney JP; Branchford BR; Brodsky GL; Cosmic MS; Calabrese DW; Aquilante CL; Maloney KW; Gonzalez JR; Zhang W; Moreau KL; Wiggins KL; Smith NL; Broeckel U; Di Paola J
FASEB J; 2017 Jul; 31(7):2771-2784. PubMed ID: 28302652
[TBL] [Abstract] [Full Text] [Related]
10. A Differential Item Functioning Analysis of the EQ-5D in cancer.
Smith AB; Cocks K; Parry D; Taylor M
Value Health; 2016 Dec; 19(8):1063-1067. PubMed ID: 27987634
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Schrock AB; Frampton GM; Herndon D; Greenbowe JR; Wang K; Lipson D; Yelensky R; Chalmers ZR; Chmielecki J; Elvin JA; Wollner M; Dvir A; -Gutman LS; Bordoni R; Peled N; Braiteh F; Raez L; Erlich R; Ou SH; Mohamed M; Ross JS; Stephens PJ; Ali SM; Miller VA
Clin Cancer Res; 2016 Jul; 22(13):3281-5. PubMed ID: 26933124
[TBL] [Abstract] [Full Text] [Related]
12. Mitochondrial Reprogramming Regulates Breast cancer Progression.
Kannan A; Wells RB; Sivakumar S; Komatsu S; Singh KP; Samten B; Philley JV; Sauter ER; Ikebe M; Idell S; Gupta S; Dasgupta S
Clin Cancer Res; 2016 Jul; 22(13):3348-60. PubMed ID: 26888829
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and Molecular Characteristics of NF1-Mutant lung cancer.
Redig AJ; Capelletti M; Dahlberg SE; Sholl LM; Mach S; Fontes C; Shi Y; Chalasani P; Jänne PA
Clin Cancer Res; 2016 Jul; 22(13):3148-56. PubMed ID: 26861459
[TBL] [Abstract] [Full Text] [Related]
14. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Von Hoff DD; Mita MM; Ramanathan RK; Weiss GJ; Mita AC; LoRusso PM; Burris HA; Hart LL; Low SC; Parsons DM; Zale SE; Summa JM; Youssoufian H; Sachdev JC
Clin Cancer Res; 2016 Jul; 22(13):3157-63. PubMed ID: 26847057
[TBL] [Abstract] [Full Text] [Related]
15. A Novel Epigenetic Signature for Early Diagnosis in lung cancer.
Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
[TBL] [Abstract] [Full Text] [Related]
16. Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the negative exponential model.
Fry JS; Lee PN; Forey BA; Coombs KJ
Regul Toxicol Pharmacol; 2015 Jun; 72(1):49-57. PubMed ID: 25703436
[TBL] [Abstract] [Full Text] [Related]
17. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
[TBL] [Abstract] [Full Text] [Related]
18. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
Santegoets SJ; Turksma AW; Suhoski MM; Stam AG; Albelda SM; Hooijberg E; Scheper RJ; van den Eertwegh AJ; Gerritsen WR; Powell DJ; June CH; de Gruijl TD
J Transl Med; 2013 Feb; 11():37. PubMed ID: 23402380
[TBL] [Abstract] [Full Text] [Related]
19. lung cancer risk among smokers of menthol cigarettes.
Blot WJ; Cohen SS; Aldrich M; McLaughlin JK; Hargreaves MK; Signorello LB
J Natl Cancer Inst; 2011 May; 103(10):810-6. PubMed ID: 21436064
[TBL] [Abstract] [Full Text] [Related]
20. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract] [Full Text] [Related]
[Next]
